MYL up +2.76% percent Today $MYL High is at 55.61 and the

New Post Public Reply Private Reply Replies (0) Message Board

Nov 17, 2014 at 11:13 AM

MYL up +2.76% percent Today $MYL High is at 55.61 and the Low 54.02 with current volume of 504,076.

Recent News posted below.

Mylan Inc MYL other info.
http://investorshangout.com/Mylan-Inc-MYL-54841/

MYL Mylan Inc Recent Headline News

AxoGen (AXGN) Looks Good: Stock Adds 5.5% in Session - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - 1 hr 26 mins ago
AxoGen (AXGN) was a big mover last session, with shares rising nearly 6% on the day.
IPXL: 28.75 (-0.11), AXGN: 2.67 (-0.02), AKRX: 38.80 (+0.59), MYL: 55.35 (+1.30)

InsiderInsights.com Daily Round Up 11/12/14: DVA, PSEC, MRC, SUMR
InsiderInsights - at Seeking Alpha - Fri Nov 14, 3:44PM CST

HAS: 56.48 (+2.46), CJES: 19.08 (-0.87), FB: 74.70 (-0.18), MRC: 21.62 (-0.34), SUMR: 2.78 (-0.09), MYL: 55.35 (+1.30), GOOG: 536.72 (-7.68), GSAT: 2.80 (-0.17), CHRS: 13.05 (-0.87), GGP: 25.72 (+0.16), DVA: 75.35 (-0.31), Q: 55.94 (+0.11), SPW: 91.87 (-0.06), RCPT: 103.96 (-2.59), DATA: 84.38 (-0.45), X: 35.70 (-0.54), PSEC: 9.64 (-0.05), SCHW: 28.65 (-0.22), ERII: 4.66 (unch)

Akorn (AKRX) Worth Watching: Stock Adds 6.4% in Session - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri Nov 14, 7:51AM CST
Akorn, Inc. (AKRX) was a big mover last session, as its shares rose over 6% on the day.
MNK: 88.95 (+0.84), KBIO: 1.98 (-0.12), AKRX: 38.80 (+0.59), MYL: 55.35 (+1.30)

Watch for Mylan to Potentially Pullback After Gaining 1.73% Yesterday
Comtex SmarTrend(R) - Thu Nov 13, 4:15PM CST
Mylan (NASDAQ:MYL) traded in a range yesterday that spanned from a low of $53.16 to a high of $56.25. Yesterday, the shares gained 1.7%, which took the trading range above the 3-day high of $54.23 on volume of 4.8 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
MYL: 55.35 (+1.30)

Mylan Set to Possibly Pullback After Yesterday's Rally of 1.73%
Comtex SmarTrend(R) - Thu Nov 13, 4:15PM CST
Mylan (NASDAQ:MYL) traded in a range yesterday that spanned from a low of $53.16 to a high of $56.25. Yesterday, the shares gained 1.7%, which took the trading range above the 3-day high of $54.23 on volume of 4.8 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
MYL: 55.35 (+1.30)

Trade-Ideas: Mylan (MYL) Is Today's "Barbarian At The Gate" Stock
at The Street - Thu Nov 13, 10:10AM CST
Trade-Ideas LLC identified Mylan (MYL) as a "barbarian at the gate" (strong stocks crossing above resistance with today's range greater than 200%) candidate
MYL: 55.35 (+1.30)

Big Cap 20 Stuffed With Medical Names
at Investor's Business Daily - Mon Nov 10, 6:34PM CST
Nine of the Big Cap 20 names this week are in medical-related fields, revealing that the leadership among these names over the past few years has continued despite October's correction, which whittled more than 10% off the Nasdaq. Alexion...
ABC: 88.88 (+0.05), VRX: 135.65 (+1.44), ALXN: 189.46 (+0.70), AMGN: 159.59 (+1.91), MYL: 55.35 (+1.30), ILMN: 181.32 (+0.82), CELG: 104.99 (+0.94)

KaloBios (KBIO) Looks Good: Stocks Adds 11.1% in Session - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Mon Nov 10, 8:25AM CST
KaloBios (KBIO) was a big mover last session, with shares rising over 11% on the day.
MNK: 88.95 (+0.84), IPXL: 28.75 (-0.11), KBIO: 1.98 (-0.12), MYL: 55.35 (+1.30)

Comparing America's 3 Largest Generic Drugs Companies
Joseph Cafariello - at Seeking Alpha - Fri Nov 07, 9:05AM CST

ZTS: 44.03 (+0.89), ACT: 251.15 (+7.38), MYL: 55.35 (+1.30)

Mylan Signs Strategic Alliance Agreement with Walt Disney Parks and Resorts to Enhance Access to EpiPen® (epinephrine) Auto-Injectors
PR Newswire - Fri Nov 07, 7:00AM CST
Mylan Inc. (Nasdaq: MYL) today announced it has signed a multi-year strategic alliance agreement with Walt Disney Parks and Resorts to help increase awareness of anaphylaxis, a life-threatening (severe) allergic reaction. The agreement includes updated maps in Disney's domestic theme parks and on its cruise ships as well as updated signage in the parks that highlight locations with EpiPen® (epinephrine) and EpiPen Jr® (epinephrine) Auto-Injectors. Over time, the companies also will introduce a variety of educational resources designed to increase awareness of and preparedness for severe allergic reactions.
MYL: 55.35 (+1.30)

Mylan reports market availability of generic Loestrin 24 Fe for contraception
M2 - Thu Nov 06, 7:27AM CST
Pharmaceutical company Mylan (NasdaqGS:MYL) revealed on Wednesday the introduction of its Norethindrone Acetate and Ethinyl Estradiol Tablets USP, 1 mg/0.02 mg and Ferrous Fumarate in the US with immediate effect.
MYL: 55.35 (+1.30)

Actavis Beats on Q3 Earnings, Guides Above Expectations - Analyst Blog
Arpita Dutt - Zacks Investment Research - Wed Nov 05, 9:16AM CST
Actavis' (ACT) third quarter results were boosted by the Forest Labs and Warner Chilcott acquisitions.
MNK: 88.95 (+0.84), ACT: 251.04 (+7.27), MYL: 55.35 (+1.30), TEVA: 57.82 (+0.75)

Quarterly Financial Results and Upcoming Conference - Research Reports on Mylan, Aegerion, Bard, Incyte and Boston Scientific
PR Newswire - Wed Nov 05, 7:50AM CST
Today, Analysts Review released its research reports regarding Mylan Inc. (NASDAQ: MYL), Aegerion Pharmaceuticals, Inc. (NASDAQ: AEGR), C.R. Bard, Inc. (NYSE: BCR), Incyte Corporation (NASDAQ: INCY) and Boston Scientific Corporation (NYSE: BSX). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.analystsreview.com/7704-100free.
BSX: 13.40 (+0.04), BCR: 164.35 (+0.31), INCY: 70.18 (+0.64), MYL: 55.35 (+1.30), AEGR: 19.77 (+0.11)

Mylan Launches Generic Loestrin 24 Fe®
PR Newswire - Wed Nov 05, 6:30AM CST
Mylan Inc. (Nasdaq: MYL) today announced the U.S. launch of its Norethindrone Acetate and Ethinyl Estradiol Tablets USP, 1 mg/0.02 mg and Ferrous Fumarate, which is the generic version of Warner Chilcott's Loestrin 24 Fe®. Mylan received final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for this product, which is indicated for the prevention of pregnancy in women who elect to use oral contraceptives as a method of contraception.(1) Mylan has begun shipping product.
MYL: 55.35 (+1.30)

Mylan Is Near All-Time High Levels But Still A Strong Buy
Kanak Kanti De - at Seeking Alpha - Mon Nov 03, 12:10PM CST

MYL: 55.35 (+1.30)

Watch for Shares of Mylan (MYL) to Approach Resistance at $53.74
Comtex SmarTrend(R) - Fri Oct 31, 12:59PM CDT
Shares of Mylan (NASDAQ:MYL) have bullishly opened above the pivot of $51.77 today and have reached the first resistance level of $53.06. Analysts will be watching for a cross of the next upside pivot targets of $53.74 and $55.71.
MYL: 55.35 (+1.30)

Teva Beats Q3 Earnings Expectations, Updates Outlook - Analyst Blog
Arpita Dutt - Zacks Investment Research - Fri Oct 31, 12:10PM CDT
Teva (TEVA) has seven U.S. launches and multiple international launches lined up for the fourth quarter.
IPXL: 28.75 (-0.11), ACT: 251.04 (+7.27), MYL: 55.35 (+1.30), TEVA: 57.82 (+0.75)

Mylan updates guidance after Q3 results
Seeking Alpha - at Seeking Alpha - Fri Oct 31, 11:38AM CDT

MYL: 55.35 (+1.30)

Mylan Rises On Q3 Earnings Beat, Affirms Abbott Deal
at Investor's Business Daily - Fri Oct 31, 10:17AM CDT
Mylan (MYL) was up 3%, near 54, in early trading in the stock market today after the drugmaker beat Q3 estimates late Thursday. Earlier, the stock was up more than 7% at a nearly eight-month high above 56. Earnings came in on the high end of the...
ABT: 43.83 (+0.02), SHPG: 204.53 (+1.91), MYL: 55.35 (+1.30), ABBV: 65.11 (+1.11)

Mylan (MYL) Earnings Report: Q3 2014 Conference Call Transcript
at The Street - Fri Oct 31, 10:16AM CDT
The following Mylan (MYL) conference call took place on October 30, 2014, 04:30 PM ET. This is a transcript of that earnings call:
MYL: 55.35 (+1.30)

Mylan Inc. (MYL) Stock Research Links

MYL Board Company Profile Buy Rating Time & Sales News Filings Financials

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

North Island Credit Union Eases Student Access to Banking

Breaking Down Barriers with Student Banking Services Stumble into any financial setup these days, and you'll hear the same refrain: young people need more access to banking. North Island Credit Union seems to have taken that idea to heart, landing a national Bank On certification for their Student Checking account. It ain't just any badge; it's the mark of reliability,...

Bechtel's $1M Push for Wyoming's Skilled Trades Future

Wyoming's Bid for Skilled Trades Revolution You’d think with all the talk about tech and white-collar jobs, we’ve forgotten the backbone that keeps the world ticking—skilled trades. Turns out, Bechtel hasn’t. The company just tossed a cool million at Wyoming's Laramie County Community College and Western Wyoming College. What’s that doing? It's jumpstarting...

DAR Logs Massive 587,000 Service Hours Nationwide

A Month of Patriotism and Service You've got to hand it to the Daughters of the American Revolution (DAR)—when they commit, they go all in. This year, they turned their usual Day of Service into a full-blown Month of Service, packing in over 587,000 hours of volunteering nationwide. From historic spots to food pantries, DAR members showed up, and honestly, it's the kind...

Casio's CMK?100: A Lightweight Marvel Blending Style and Utility

A Timepiece That Redefines Everyday Elegance There's a new player in the vast realm of watches, and it's got tongues wagging: the Casio CMK?100. You don’t see that blend of style, comfort, and practicality grow on trees, my friend. Casio’s new offering, the CMK?100, wears its purpose on its titanium sleeve: lightweight and stylish, it’s a suave addition to any wrist...

DayOne's Bold Energy Moves With Sembcorp for Asia Growth

It seems the digital world and power supply have locked in a new dance as DayOne Data Centers teams up with Sembcorp Utilities. It's high time we gave this story a solid look, especially with data centers gobbling energy faster than my old trading partner downs an espresso. Tackling Energy Constraints Head-On The digital infrastructure beast is hungry for power, and...

West Fraser Tackles Grim Quarter: Indefinite Mill Closures

Bracing For Impact: The Tough Truth About West Fraser's Recent Moves Things are looking a bit bleak over at West Fraser Timber Co. They've just dropped their Q3 2026 results, ringing the bell with a hefty $80 million loss. As if that wasn't enough, the company's decided to indefinitely curtail a couple of mills—one in Lanett, Alabama and the other in Leola, Arkansas....

Milestone's 2026 LawHER Scholars: A Step Forward for Equity

A Significant Step for Women in Law Now, here’s a twist in the legal world that actually shakes things up in a good way. Milestone and Scholarship America just rolled out the red carpet for some promising female law students. We're looking at serious cash on the table: a top prize of $25,000 plus a couple more at $10,000 each, earmarked for women stepping into a...

Eric Dalton: Redefining Homecare with Vision and Strategy

What's Behind Eric Dalton's Continued Recognition? Now, if you told me a healthcare leader’s named 'Visionary of the Year' twice in a row, my first thought isn't 'stretch goals' but 'show me the goods.' And that’s precisely what Eric J. Dalton has done. The Vice President at Angels on Call Homecare isn't just tooting his own horn; he's building a damn symphony in the...

Chesapeake Utilities Sets Stage for Q3 Earnings Review

Cashing In on Chesapeake's Dynamic Playbook Come November 6, 2026, at the ungodly hour of 8:30 a.m. ET, Chesapeake Utilities Corporation (NYSE: CPK) is opening the curtains on their third-quarter financial exploits. Now, these conference calls can be a real chess match, revealing just how the company’s pieces are positioned in this energy game. Buckle up, because the...

BellRing Brands Lawsuit Hinges on Sales Misrepresentation

BellRing's Legal Tangle Deepens When it comes to drawing the line between having a good quarter and pulling the wool over investors' eyes, the latest lawsuit knotted up with BellRing Brands, Inc. (NYSE: BRBR) shows just how fine that line can be. This legal drama, filed on the not-so-distant date of January 22, 2026, isn't your garden-variety beef. We're talking...